Study on Pathogen of Lower Respiratory Tract Infection in Children in Pediatric Intensive Care Unit and Common Ward

doi:10.3877/cma.j.issn.1673-5250.2012.06.017

Objective

To investigate the pathogen of low respiratory tract infection in children in pediatric intensive care unit (PICU) and common ward.

Methods

From May to July, 2011, a total of 397 cases (240 boys and 157 girls) with low respiratory tract infection were included into this study. They were divided into two groups, PICU group (n=77) and common ward group (n=320). There had no significant differences in age and gender between two groups (P>0.05). The study protocol was approved by the Ethical Review Board of Investigation in Human Being of Maternity and Child Care Hospital of Guangxi Zhuang Autonomous Region. Informed consent was obtained from all participates' parents. The samples were collected from two groups for the test of indirect immunofluorescence assay (FIA). The following items were detected, IgM antibody of 5 viruses (7 types), including respiratory syncytial virus (RSV), adenovirus(ADV), influenza virus type A (IV-A), influenza virus type B (IV-B), parainfluenza virus type (PIV-1, 2, 3) and 4 atypical pathogens, including Mycoplasma pneumonia (MP), Legionella pneumophila 1 (LP 1), Chlamydia pneumonia (CPn), Q fever rickettsia (QFR).

Results

Among PICU group (n=77), positive rate of pathogen was 55.84% (43/77), of which, atypical pathogens detected rate was 68.83% (53/77), and virus detected rate was 19.48% (15/77), mixed infection were detected in 22 of 43 positive infectors (51.16%). Among common ward group (n=320), positive rate of pathogen was 35.94% (115/320), of which, atypical pathogens detected rate was 42.5% (136/320), and virus detected rate was 16.56% (53/320), mixed infection were detected in 58 of 115 positive infectors (50.43%). MP was the most common pathogen with higher positive rate of two groups (41.56% vs. 24.69%).

Conclusions

Atypical pathogens was the mostly pathogen of lower respiratory tract infection in pediatric clinics, especially PICU children. Further more, dual mixed infections (MP + LP 1) is the most prevalent.

Key words: respiratory tract infection, atypical pathogen, virus, pediatric intensive care unit, common ward

表1 非典型病原体感染情况[n(%)]

Table 1 Statistics of atypical pathogens infections [n(%)]

组别	n	MP	LP1	QFR	CPn	合计
普通病房组	320	79(24.69)	36(11.25)	19 (5.94)	2(0.63)	136(42.50)
PICU组	77	32(41.56)	12(15.58)	8(10.39)	1(1.30)	53(68.83)
χ²	?	8.77	0.19	1.94	0.38	17.25
P	?	<0.01	>0.05	>0.05	>0.05	< 0.01

表1 非典型病原体感染情况[n(%)]

Table 1 Statistics of atypical pathogens infections [n(%)]

组别	n	MP	LP1	QFR	CPn	合计
普通病房组	320	79(24.69)	36(11.25)	19 (5.94)	2(0.63)	136(42.50)
PICU组	77	32(41.56)	12(15.58)	8(10.39)	1(1.30)	53(68.83)
χ²	?	8.77	0.19	1.94	0.38	17.25
P	?	<0.01	>0.05	>0.05	>0.05	< 0.01

表2 病毒感染情况[n(%)]

Table 2 Statistics of virus infections [n(%)]

组别	n	RSV	IV－B	PIV－1，2，3	IV－A	ADV	合计
普通病房组	320	24 (7.50)	21(6.56)	7(2.19)	1(0.31)	0(0.00)	53(16.56)
PICU组	77	11(14.29)	1(1.30)	0(0.00)	1(1.30)	2(2.60)	15(19.48)
χ²	?	3.55	3.29	1.71	1.20	10.99	0.37
P	?	>0.05	>0.05	>0.05	>0.05	< 0.01	>0.05

表2 病毒感染情况[n(%)]

Table 2 Statistics of virus infections [n(%)]

组别	n	RSV	IV－B	PIV－1，2，3	IV－A	ADV	合计
普通病房组	320	24 (7.50)	21(6.56)	7(2.19)	1(0.31)	0(0.00)	53(16.56)
PICU组	77	11(14.29)	1(1.30)	0(0.00)	1(1.30)	2(2.60)	15(19.48)
χ²	?	3.55	3.29	1.71	1.20	10.99	0.37
P	?	>0.05	>0.05	>0.05	>0.05	< 0.01	>0.05

表3 病原混合感染情况[n(%)]

Table 3 Statistics of the mix－infection [n(%)]

组别	n	MP＋LP 1	MP＋QFR	MP＋RSV	MP＋IV－B	MP＋RSV＋QFR	RSV＋IV－B
普通病房组	115	17(14.78)	5(4.35)	5(4.35)	4(3.48)	5(4.35)	7(6.09)
PICU组	43	7(16.28)	3(6.98)	4(9.30)	1(2.33)	0(0.00)	0(0.00)
χ²	?	0.05	0.45	1.43	0.14	1.93	2.74
P	?	>0.05	>0.05	>0.05	>0.05	>0.05	>0.05

表3 病原混合感染情况[n(%)]

Table 3 Statistics of the mix－infection [n(%)]

组别	n	MP＋LP 1	MP＋QFR	MP＋RSV	MP＋IV－B	MP＋RSV＋QFR	RSV＋IV－B
普通病房组	115	17(14.78)	5(4.35)	5(4.35)	4(3.48)	5(4.35)	7(6.09)
PICU组	43	7(16.28)	3(6.98)	4(9.30)	1(2.33)	0(0.00)	0(0.00)
χ²	?	0.05	0.45	1.43	0.14	1.93	2.74
P	?	>0.05	>0.05	>0.05	>0.05	>0.05	>0.05

[1]	Deng JK, Zheng YJ, Yuan XW, et al.Etiology monitoring in the children suffer from acute lower respiratory tract infection in Shenzhen[J]. Chin J Child Health Care, 2007, 15(3):249-251.
[2]	Wu Q, Ni LX, Fan M, et al. An retrospective analysis of nonrepresentative pathogen infection of the children in Kunming region[J]. Chin J Child Health Care, 2009, 17(6):708-710.
[3]	Sun LX, Huang JF, Zhang H. Research of virus pathogen spectra of children lower respiratory tract infection in Tianjin region[J]. China J Mod Med, 2004, 14(24):129-130.
[4]	Zeng M, Wang XH, Yu H, et al. Epidemiological characteristics of common respiratory viruses among children with acute respiratory tract infections in Shanghai[J]？Chin J Infect Dis, 2008, 26(9):527-532.
[5]	Hu YM, Jiang ZF, ed. Zhu Futang practice of pediatrics. 7th ed[M]. Beijing:People's Medical Publishing House, 2002, 1171-1181.
[6]	Naghipour M, Cuevas LE, Bakhshinejad T, et al. Contribution of viruses, Chlamydia spp. and Mycoplasma pneumoniae to acute respiratory infections in Iranian children[J].J Trop Pediatr, 2007, 53(3):179-184.
[7]	Wu Q, Ni LX, Fan M, et al. A clinical analysis of mycoplasma pneumonia and legionella pneumophila 1 infection in 97 children[J]. China Mod Doctor, 2010, 48(4):133-134.
[8]	Farshad N, Saffar MJ, Khalilian AR, et al. Respiratory viruses in hospitalized children with acute lower respiratory tract infections[J]. Indian Pediatr, 2008, 45(7):590-592.

[1]	Chen Luo, Kaican Zong, Shiying Li, Yingya Fu. MicroRNA-199a-3p participates in the immune response after Mycoplasma pneumoniae infection in children by regulating the expression of CD4⁺ T cells[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2023, 19(05): 569-574.
[2]	Anqi Li, Yilin Xu, Tianxin Xiang. Progress on diagnosis and treatment of post corona virus disease 2019 pulmonary fibrosis[J]. Chinese Journal of Experimental and Clinical Infectious Diseases(Electronic Edition), 2023, 17(05): 294-298.
[3]	Xiaoman Zhang, Xiaoqiu Ma, Zhengju Xu, Chunyu Zhang, Caiting He. Effect of drug-resistant mutations in reverse transcriptase region of hepatitis B virus on the level of serum hepatitis B surface antigen[J]. Chinese Journal of Experimental and Clinical Infectious Diseases(Electronic Edition), 2023, 17(05): 324-332.
[4]	Yu Zhang, Wenrui Xue, Xin Wang, Xuyu Li, Xudong Wang, Pengfei Yuan, Yurun Liang, Zhixing Han, Haijian Zhang, Qingjun Liu, Shiqi Ji. Clinical features of 14 cases with bladder cancer infected with human immunodeficiency virus[J]. Chinese Journal of Experimental and Clinical Infectious Diseases(Electronic Edition), 2023, 17(05): 354-358.
[5]	Yingying Wang, Ping Xie. Risk factors of liver injury in patients with hepatitis B virus infection and pulmonary tuberculosis and predictive model construction[J]. Chinese Journal of Experimental and Clinical Infectious Diseases(Electronic Edition), 2023, 17(04): 267-273.
[6]	Lingjie Wu, Ruilie Chen, Guijia Chen, Xiangming Xiao, Zhongbin Lin. Antiviral treatment of two cases with human immunodeficiency virus complicated with severe acute respiratory syndrome coronavirus 2 co-infection and literatures review[J]. Chinese Journal of Experimental and Clinical Infectious Diseases(Electronic Edition), 2023, 17(04): 282-286.
[7]	Fangyuan Wu, Xia Sun, Changfeng Lin, Zhensheng Zhang. Risk factors of HBV-associated cirrhosis complicated with acute upper gastrointestinal bleeding[J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2024, 18(01): 45-47.
[8]	Shuoru Liu, Gongwei Wang, Bin Zhang, Shuhao Li, Cheng Hu. Oncolytic virus M1 activates endoplasmic reticulum stress pathway to induce apoptosis of prostate cancer cells[J]. Chinese Journal of Endourology(Electronic Edition), 2023, 17(04): 388-393.
[9]	Hongmin Wang, Yunbo Xie, Yanhu Wang, Fusheng Wang. The advance of clinical research in mesenchymal stem cell treatment for COVID-19[J]. Chinese Journal of Cell and Stem Cell(Electronic Edition), 2023, 13(04): 247-256.
[10]	Shudian Chen, Yun Liang, Yuan Liao, Yang Wang. Prognostic value of complement C3 in patients with HBV-related acute-on-chronic liver failure[J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2023, 12(05): 562-566.
[11]	Xigang Wang, Bo Zhang, Ming Li, Min Gao, Jianxin Xue. Clinical analysis of neurosurgical site infection in HIV-infected and non-HIV-infected patiends[J]. Chinese Journal of Neurotraumatic Surgery(Electronic Edition), 2023, 09(04): 228-233.
[12]	Xiaojuan Han, Jiaqian Xu, Yulan Zhu, Ying Wang, Yuan Li, Jun Feng, Dong Shao. Construction and cell function study of HHLA2-overexpressing gastric cancer cells[J]. Chinese Journal of Digestion and Medical Imageology(Electronic Edition), 2023, 13(06): 373-377.
[13]	Xinqiang Xu, Xuesong Li, Weiye He, Qionghua Tang. Analysis of influenza A and influenza B epidemic in Baiyun district of Guangzhou in 2019[J]. Chinese Journal of Clinical Laboratory Management(Electronic Edition), 2023, 11(04): 230-234.
[14]	Qingyao Du, Yingwen Cao, Jianxiong Lin, Run Hao, Jingmin Wang, Ruiquan Xu, Xiaoxia Kou. Mechanism of gut flora promoting Norovirus infection[J]. Chinese Journal of Clinical Laboratory Management(Electronic Edition), 2023, 11(04): 241-244,255.
[15]	Danyang Tian, Xiaoxuan Liu, Shan Ye, Xinran Ma, Dongsheng Fan, Yu Fu. The impact of COVID-19 on the standardized training of neurology residents[J]. Chinese Journal of Cerebrovascular Diseases(Electronic Edition), 2023, 17(05): 499-504.

Viewed

Full text

Abstract

Please choose a citation manager

Content to export